List of Tables
Table 1. Global Diagnostic Nuclear Medicines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Tc-99m
Table 3. Major Manufacturers of F-18
Table 4. Major Manufacturers of Other
Table 5. Global Diagnostic Nuclear Medicines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Diagnostic Nuclear Medicines Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 7. Global Diagnostic Nuclear Medicines Revenue by Region (2019-2024) & (US$ Million)
Table 8. Global Diagnostic Nuclear Medicines Revenue by Region (2025-2030) & (US$ Million)
Table 9. Global Diagnostic Nuclear Medicines Revenue Market Share by Region (2019-2024)
Table 10. Global Diagnostic Nuclear Medicines Revenue Market Share by Region (2025-2030)
Table 11. Global Diagnostic Nuclear Medicines Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 12. Global Diagnostic Nuclear Medicines Sales by Region (2019-2024) & (K Units)
Table 13. Global Diagnostic Nuclear Medicines Sales by Region (2025-2030) & (K Units)
Table 14. Global Diagnostic Nuclear Medicines Sales Market Share by Region (2019-2024)
Table 15. Global Diagnostic Nuclear Medicines Sales Market Share by Region (2025-2030)
Table 16. Global Diagnostic Nuclear Medicines Sales by Manufacturers (2019-2024) & (K Units)
Table 17. Global Diagnostic Nuclear Medicines Sales Share by Manufacturers (2019-2024)
Table 18. Global Diagnostic Nuclear Medicines Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 19. Global Diagnostic Nuclear Medicines Revenue Share by Manufacturers (2019-2024)
Table 20. Global Key Players of Diagnostic Nuclear Medicines, Industry Ranking, 2022 VS 2023 VS 2024
Table 21. Diagnostic Nuclear Medicines Price by Manufacturers 2019-2024 (USD/Unit)
Table 22. Global Diagnostic Nuclear Medicines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Diagnostic Nuclear Medicines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Nuclear Medicines as of 2023)
Table 24. Global Key Manufacturers of Diagnostic Nuclear Medicines, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Diagnostic Nuclear Medicines, Product Offered and Application
Table 26. Global Key Manufacturers of Diagnostic Nuclear Medicines, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Diagnostic Nuclear Medicines Sales by Type (2019-2024) & (K Units)
Table 29. Global Diagnostic Nuclear Medicines Sales by Type (2025-2030) & (K Units)
Table 30. Global Diagnostic Nuclear Medicines Sales Share by Type (2019-2024)
Table 31. Global Diagnostic Nuclear Medicines Sales Share by Type (2025-2030)
Table 32. Global Diagnostic Nuclear Medicines Revenue by Type (2019-2024) & (US$ Million)
Table 33. Global Diagnostic Nuclear Medicines Revenue by Type (2025-2030) & (US$ Million)
Table 34. Global Diagnostic Nuclear Medicines Revenue Share by Type (2019-2024)
Table 35. Global Diagnostic Nuclear Medicines Revenue Share by Type (2025-2030)
Table 36. Diagnostic Nuclear Medicines Price by Type (2019-2024) & (USD/Unit)
Table 37. Global Diagnostic Nuclear Medicines Price Forecast by Type (2025-2030) & (USD/Unit)
Table 38. Global Diagnostic Nuclear Medicines Sales by Application (2019-2024) & (K Units)
Table 39. Global Diagnostic Nuclear Medicines Sales by Application (2025-2030) & (K Units)
Table 40. Global Diagnostic Nuclear Medicines Sales Share by Application (2019-2024)
Table 41. Global Diagnostic Nuclear Medicines Sales Share by Application (2025-2030)
Table 42. Global Diagnostic Nuclear Medicines Revenue by Application (2019-2024) & (US$ Million)
Table 43. Global Diagnostic Nuclear Medicines Revenue by Application (2025-2030) & (US$ Million)
Table 44. Global Diagnostic Nuclear Medicines Revenue Share by Application (2019-2024)
Table 45. Global Diagnostic Nuclear Medicines Revenue Share by Application (2025-2030)
Table 46. Diagnostic Nuclear Medicines Price by Application (2019-2024) & (USD/Unit)
Table 47. Global Diagnostic Nuclear Medicines Price Forecast by Application (2025-2030) & (USD/Unit)
Table 48. US & Canada Diagnostic Nuclear Medicines Sales by Type (2019-2024) & (K Units)
Table 49. US & Canada Diagnostic Nuclear Medicines Sales by Type (2025-2030) & (K Units)
Table 50. US & Canada Diagnostic Nuclear Medicines Revenue by Type (2019-2024) & (US$ Million)
Table 51. US & Canada Diagnostic Nuclear Medicines Revenue by Type (2025-2030) & (US$ Million)
Table 52. US & Canada Diagnostic Nuclear Medicines Sales by Application (2019-2024) & (K Units)
Table 53. US & Canada Diagnostic Nuclear Medicines Sales by Application (2025-2030) & (K Units)
Table 54. US & Canada Diagnostic Nuclear Medicines Revenue by Application (2019-2024) & (US$ Million)
Table 55. US & Canada Diagnostic Nuclear Medicines Revenue by Application (2025-2030) & (US$ Million)
Table 56. US & Canada Diagnostic Nuclear Medicines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 57. US & Canada Diagnostic Nuclear Medicines Revenue by Country (2019-2024) & (US$ Million)
Table 58. US & Canada Diagnostic Nuclear Medicines Revenue by Country (2025-2030) & (US$ Million)
Table 59. US & Canada Diagnostic Nuclear Medicines Sales by Country (2019-2024) & (K Units)
Table 60. US & Canada Diagnostic Nuclear Medicines Sales by Country (2025-2030) & (K Units)
Table 61. Europe Diagnostic Nuclear Medicines Sales by Type (2019-2024) & (K Units)
Table 62. Europe Diagnostic Nuclear Medicines Sales by Type (2025-2030) & (K Units)
Table 63. Europe Diagnostic Nuclear Medicines Revenue by Type (2019-2024) & (US$ Million)
Table 64. Europe Diagnostic Nuclear Medicines Revenue by Type (2025-2030) & (US$ Million)
Table 65. Europe Diagnostic Nuclear Medicines Sales by Application (2019-2024) & (K Units)
Table 66. Europe Diagnostic Nuclear Medicines Sales by Application (2025-2030) & (K Units)
Table 67. Europe Diagnostic Nuclear Medicines Revenue by Application (2019-2024) & (US$ Million)
Table 68. Europe Diagnostic Nuclear Medicines Revenue by Application (2025-2030) & (US$ Million)
Table 69. Europe Diagnostic Nuclear Medicines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 70. Europe Diagnostic Nuclear Medicines Revenue by Country (2019-2024) & (US$ Million)
Table 71. Europe Diagnostic Nuclear Medicines Revenue by Country (2025-2030) & (US$ Million)
Table 72. Europe Diagnostic Nuclear Medicines Sales by Country (2019-2024) & (K Units)
Table 73. Europe Diagnostic Nuclear Medicines Sales by Country (2025-2030) & (K Units)
Table 74. China Diagnostic Nuclear Medicines Sales by Type (2019-2024) & (K Units)
Table 75. China Diagnostic Nuclear Medicines Sales by Type (2025-2030) & (K Units)
Table 76. China Diagnostic Nuclear Medicines Revenue by Type (2019-2024) & (US$ Million)
Table 77. China Diagnostic Nuclear Medicines Revenue by Type (2025-2030) & (US$ Million)
Table 78. China Diagnostic Nuclear Medicines Sales by Application (2019-2024) & (K Units)
Table 79. China Diagnostic Nuclear Medicines Sales by Application (2025-2030) & (K Units)
Table 80. China Diagnostic Nuclear Medicines Revenue by Application (2019-2024) & (US$ Million)
Table 81. China Diagnostic Nuclear Medicines Revenue by Application (2025-2030) & (US$ Million)
Table 82. Asia Diagnostic Nuclear Medicines Sales by Type (2019-2024) & (K Units)
Table 83. Asia Diagnostic Nuclear Medicines Sales by Type (2025-2030) & (K Units)
Table 84. Asia Diagnostic Nuclear Medicines Revenue by Type (2019-2024) & (US$ Million)
Table 85. Asia Diagnostic Nuclear Medicines Revenue by Type (2025-2030) & (US$ Million)
Table 86. Asia Diagnostic Nuclear Medicines Sales by Application (2019-2024) & (K Units)
Table 87. Asia Diagnostic Nuclear Medicines Sales by Application (2025-2030) & (K Units)
Table 88. Asia Diagnostic Nuclear Medicines Revenue by Application (2019-2024) & (US$ Million)
Table 89. Asia Diagnostic Nuclear Medicines Revenue by Application (2025-2030) & (US$ Million)
Table 90. Asia Diagnostic Nuclear Medicines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 91. Asia Diagnostic Nuclear Medicines Revenue by Region (2019-2024) & (US$ Million)
Table 92. Asia Diagnostic Nuclear Medicines Revenue by Region (2025-2030) & (US$ Million)
Table 93. Asia Diagnostic Nuclear Medicines Sales by Region (2019-2024) & (K Units)
Table 94. Asia Diagnostic Nuclear Medicines Sales by Region (2025-2030) & (K Units)
Table 95. Middle East, Africa and Latin America Diagnostic Nuclear Medicines Sales by Type (2019-2024) & (K Units)
Table 96. Middle East, Africa and Latin America Diagnostic Nuclear Medicines Sales by Type (2025-2030) & (K Units)
Table 97. Middle East, Africa and Latin America Diagnostic Nuclear Medicines Revenue by Type (2019-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Diagnostic Nuclear Medicines Revenue by Type (2025-2030) & (US$ Million)
Table 99. Middle East, Africa and Latin America Diagnostic Nuclear Medicines Sales by Application (2019-2024) & (K Units)
Table 100. Middle East, Africa and Latin America Diagnostic Nuclear Medicines Sales by Application (2025-2030) & (K Units)
Table 101. Middle East, Africa and Latin America Diagnostic Nuclear Medicines Revenue by Application (2019-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Diagnostic Nuclear Medicines Revenue by Application (2025-2030) & (US$ Million)
Table 103. Middle East, Africa and Latin America Diagnostic Nuclear Medicines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 104. Middle East, Africa and Latin America Diagnostic Nuclear Medicines Revenue by Country (2019-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Diagnostic Nuclear Medicines Revenue by Country (2025-2030) & (US$ Million)
Table 106. Middle East, Africa and Latin America Diagnostic Nuclear Medicines Sales by Country (2019-2024) & (K Units)
Table 107. Middle East, Africa and Latin America Diagnostic Nuclear Medicines Sales by Country (2025-2030) & (K Units)
Table 108. Cardinal Health Company Information
Table 109. Cardinal Health Description and Major Businesses
Table 110. Cardinal Health Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 111. Cardinal Health Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Cardinal Health Recent Developments
Table 113. GE Healthcare Company Information
Table 114. GE Healthcare Description and Major Businesses
Table 115. GE Healthcare Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 116. GE Healthcare Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. GE Healthcare Recent Developments
Table 118. Curium Pharma Company Information
Table 119. Curium Pharma Description and Major Businesses
Table 120. Curium Pharma Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 121. Curium Pharma Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Curium Pharma Recent Developments
Table 123. Jubilant Pharma Company Information
Table 124. Jubilant Pharma Description and Major Businesses
Table 125. Jubilant Pharma Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 126. Jubilant Pharma Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Jubilant Pharma Recent Developments
Table 128. Bracco Imaging Company Information
Table 129. Bracco Imaging Description and Major Businesses
Table 130. Bracco Imaging Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 131. Bracco Imaging Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Bracco Imaging Recent Developments
Table 133. Novartis Company Information
Table 134. Novartis Description and Major Businesses
Table 135. Novartis Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 136. Novartis Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Novartis Recent Developments
Table 138. SIEMENS Company Information
Table 139. SIEMENS Description and Major Businesses
Table 140. SIEMENS Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 141. SIEMENS Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. SIEMENS Recent Developments
Table 143. China Isotope & Radiation Company Information
Table 144. China Isotope & Radiation Description and Major Businesses
Table 145. China Isotope & Radiation Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 146. China Isotope & Radiation Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. China Isotope & Radiation Recent Developments
Table 148. Dongcheng Company Information
Table 149. Dongcheng Description and Major Businesses
Table 150. Dongcheng Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 151. Dongcheng Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Dongcheng Recent Developments
Table 153. Lantheus Company Information
Table 154. Lantheus Description and Major Businesses
Table 155. Lantheus Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 156. Lantheus Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Lantheus Recent Developments
Table 158. Eli Lilly Company Information
Table 159. Eli Lilly Description and Major Businesses
Table 160. Eli Lilly Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 161. Eli Lilly Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Eli Lilly Recent Developments
Table 163. Key Raw Materials Lists
Table 164. Raw Materials Key Suppliers Lists
Table 165. Diagnostic Nuclear Medicines Distributors List
Table 166. Diagnostic Nuclear Medicines Customers List
Table 167. Diagnostic Nuclear Medicines Market Trends
Table 168. Diagnostic Nuclear Medicines Market Drivers
Table 169. Diagnostic Nuclear Medicines Market Challenges
Table 170. Diagnostic Nuclear Medicines Market Restraints
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
List of Figures
Figure 1. Diagnostic Nuclear Medicines Product Picture
Figure 2. Global Diagnostic Nuclear Medicines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Diagnostic Nuclear Medicines Market Share by Type in 2023 & 2030
Figure 4. Tc-99m Product Picture
Figure 5. F-18 Product Picture
Figure 6. Other Product Picture
Figure 7. Global Diagnostic Nuclear Medicines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 8. Global Diagnostic Nuclear Medicines Market Share by Application in 2023 & 2030
Figure 9. Oncology
Figure 10. Cardiology
Figure 11. Other
Figure 12. Diagnostic Nuclear Medicines Report Years Considered
Figure 13. Global Diagnostic Nuclear Medicines Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Diagnostic Nuclear Medicines Revenue 2019-2030 (US$ Million)
Figure 15. Global Diagnostic Nuclear Medicines Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 16. Global Diagnostic Nuclear Medicines Revenue Market Share by Region (2019-2030)
Figure 17. Global Diagnostic Nuclear Medicines Sales 2019-2030 ((K Units)
Figure 18. Global Diagnostic Nuclear Medicines Sales Market Share by Region (2019-2030)
Figure 19. US & Canada Diagnostic Nuclear Medicines Sales YoY (2019-2030) & (K Units)
Figure 20. US & Canada Diagnostic Nuclear Medicines Revenue YoY (2019-2030) & (US$ Million)
Figure 21. Europe Diagnostic Nuclear Medicines Sales YoY (2019-2030) & (K Units)
Figure 22. Europe Diagnostic Nuclear Medicines Revenue YoY (2019-2030) & (US$ Million)
Figure 23. China Diagnostic Nuclear Medicines Sales YoY (2019-2030) & (K Units)
Figure 24. China Diagnostic Nuclear Medicines Revenue YoY (2019-2030) & (US$ Million)
Figure 25. Asia (excluding China) Diagnostic Nuclear Medicines Sales YoY (2019-2030) & (K Units)
Figure 26. Asia (excluding China) Diagnostic Nuclear Medicines Revenue YoY (2019-2030) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Diagnostic Nuclear Medicines Sales YoY (2019-2030) & (K Units)
Figure 28. Middle East, Africa and Latin America Diagnostic Nuclear Medicines Revenue YoY (2019-2030) & (US$ Million)
Figure 29. The Diagnostic Nuclear Medicines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 30. The Top 5 and 10 Largest Manufacturers of Diagnostic Nuclear Medicines in the World: Market Share by Diagnostic Nuclear Medicines Revenue in 2023
Figure 31. Global Diagnostic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 32. Global Diagnostic Nuclear Medicines Sales Market Share by Type (2019-2030)
Figure 33. Global Diagnostic Nuclear Medicines Revenue Market Share by Type (2019-2030)
Figure 34. Global Diagnostic Nuclear Medicines Sales Market Share by Application (2019-2030)
Figure 35. Global Diagnostic Nuclear Medicines Revenue Market Share by Application (2019-2030)
Figure 36. US & Canada Diagnostic Nuclear Medicines Sales Market Share by Type (2019-2030)
Figure 37. US & Canada Diagnostic Nuclear Medicines Revenue Market Share by Type (2019-2030)
Figure 38. US & Canada Diagnostic Nuclear Medicines Sales Market Share by Application (2019-2030)
Figure 39. US & Canada Diagnostic Nuclear Medicines Revenue Market Share by Application (2019-2030)
Figure 40. US & Canada Diagnostic Nuclear Medicines Revenue Share by Country (2019-2030)
Figure 41. US & Canada Diagnostic Nuclear Medicines Sales Share by Country (2019-2030)
Figure 42. U.S. Diagnostic Nuclear Medicines Revenue (2019-2030) & (US$ Million)
Figure 43. Canada Diagnostic Nuclear Medicines Revenue (2019-2030) & (US$ Million)
Figure 44. Europe Diagnostic Nuclear Medicines Sales Market Share by Type (2019-2030)
Figure 45. Europe Diagnostic Nuclear Medicines Revenue Market Share by Type (2019-2030)
Figure 46. Europe Diagnostic Nuclear Medicines Sales Market Share by Application (2019-2030)
Figure 47. Europe Diagnostic Nuclear Medicines Revenue Market Share by Application (2019-2030)
Figure 48. Europe Diagnostic Nuclear Medicines Revenue Share by Country (2019-2030)
Figure 49. Europe Diagnostic Nuclear Medicines Sales Share by Country (2019-2030)
Figure 50. Germany Diagnostic Nuclear Medicines Revenue (2019-2030) & (US$ Million)
Figure 51. France Diagnostic Nuclear Medicines Revenue (2019-2030) & (US$ Million)
Figure 52. U.K. Diagnostic Nuclear Medicines Revenue (2019-2030) & (US$ Million)
Figure 53. Italy Diagnostic Nuclear Medicines Revenue (2019-2030) & (US$ Million)
Figure 54. Russia Diagnostic Nuclear Medicines Revenue (2019-2030) & (US$ Million)
Figure 55. China Diagnostic Nuclear Medicines Sales Market Share by Type (2019-2030)
Figure 56. China Diagnostic Nuclear Medicines Revenue Market Share by Type (2019-2030)
Figure 57. China Diagnostic Nuclear Medicines Sales Market Share by Application (2019-2030)
Figure 58. China Diagnostic Nuclear Medicines Revenue Market Share by Application (2019-2030)
Figure 59. Asia Diagnostic Nuclear Medicines Sales Market Share by Type (2019-2030)
Figure 60. Asia Diagnostic Nuclear Medicines Revenue Market Share by Type (2019-2030)
Figure 61. Asia Diagnostic Nuclear Medicines Sales Market Share by Application (2019-2030)
Figure 62. Asia Diagnostic Nuclear Medicines Revenue Market Share by Application (2019-2030)
Figure 63. Asia Diagnostic Nuclear Medicines Revenue Share by Region (2019-2030)
Figure 64. Asia Diagnostic Nuclear Medicines Sales Share by Region (2019-2030)
Figure 65. Japan Diagnostic Nuclear Medicines Revenue (2019-2030) & (US$ Million)
Figure 66. South Korea Diagnostic Nuclear Medicines Revenue (2019-2030) & (US$ Million)
Figure 67. China Taiwan Diagnostic Nuclear Medicines Revenue (2019-2030) & (US$ Million)
Figure 68. Southeast Asia Diagnostic Nuclear Medicines Revenue (2019-2030) & (US$ Million)
Figure 69. India Diagnostic Nuclear Medicines Revenue (2019-2030) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Diagnostic Nuclear Medicines Sales Market Share by Type (2019-2030)
Figure 71. Middle East, Africa and Latin America Diagnostic Nuclear Medicines Revenue Market Share by Type (2019-2030)
Figure 72. Middle East, Africa and Latin America Diagnostic Nuclear Medicines Sales Market Share by Application (2019-2030)
Figure 73. Middle East, Africa and Latin America Diagnostic Nuclear Medicines Revenue Market Share by Application (2019-2030)
Figure 74. Middle East, Africa and Latin America Diagnostic Nuclear Medicines Revenue Share by Country (2019-2030)
Figure 75. Middle East, Africa and Latin America Diagnostic Nuclear Medicines Sales Share by Country (2019-2030)
Figure 76. Brazil Diagnostic Nuclear Medicines Revenue (2019-2030) & (US$ Million)
Figure 77. Mexico Diagnostic Nuclear Medicines Revenue (2019-2030) & (US$ Million)
Figure 78. Turkey Diagnostic Nuclear Medicines Revenue (2019-2030) & (US$ Million)
Figure 79. Israel Diagnostic Nuclear Medicines Revenue (2019-2030) & (US$ Million)
Figure 80. GCC Countries Diagnostic Nuclear Medicines Revenue (2019-2030) & (US$ Million)
Figure 81. Diagnostic Nuclear Medicines Value Chain
Figure 82. Diagnostic Nuclear Medicines Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed